<p>ZEO Scientifix Inc. has appointed Dr. John D. Kisiday as its new Chief Science Officer, effective January 23, 2026. Dr. Kisiday brings nearly 30 years of experience in tissue engineering and regenerative medicine to the role. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ZEO Scientifix Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001829126-26-000610), on January 28, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here</p>

ZEOX

<p>ZEO Scientifix Inc. has appointed Dr. John D. Kisiday as Chief Science Officer, effective January 23, 2026. Dr. Kisiday has nearly 30 years of experience in tissue engineering and regenerative medicine.</p>

ZEO Scientifix Appoints Dr. John Kisiday as Chief Science Officer